Literature DB >> 20432151

Identification of volatile organic compounds in leaves, roots and gum of Astragalus compactus Lam. using solid phase microextraction followed by GC-MS analysis.

A Movafeghi1, Dj Djozan, J A Razeghi, T Baheri.   

Abstract

A solid phase microextraction sampling method using pencil-lead fibre coupled with gas chromatography-mass spectrometry was used to monitor the organic volatile compounds of the roots, leaves and gum of Astragalus compactus. Under optimised conditions, a range of volatile compounds were recognised in different parts of A. compactus. Based on the results obtained, the nature and level of the volatiles vary in distinct parts of the plant. In comparison with other Astragalus species investigated, only one volatile organochlorine compound, tetradecane,1-chloro, was identified in roots. Intriguingly, the toxic chlorinated component was not detectable in the gum samples. These findings highlight the higher quality of the gum of A. compactus compared to the gums of some other Astragalus species, which are reported to be contaminated with chlorinated components.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432151     DOI: 10.1080/14786410802361446

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  9 in total

1.  Ontogenetic Variation of Total Phenolics and Antioxidant Activity in Roots, Leaves and Flowers of Astragalus compactus Lam. (Fabaceae).

Authors:  Somayeh Naghiloo; Ali Movafeghi; Abbas Delazar; Hossein Nazemiyeh; Solmaz Asnaashari; Mohammad Reza Dadpour
Journal:  Bioimpacts       Date:  2012-05-21

2.  Structural Characterization and Evaluation of the Antioxidant Activity of Phenolic Compounds from Astragalus taipaishanensis and Their Structure-Activity Relationship.

Authors:  Wenjun Pu; Dongmei Wang; Dan Zhou
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

3.  Ontogenetic variation of volatiles and antioxidant activity in leaves of Astragalus compactus Lam. (Fabaceae).

Authors:  Somayeh Naghiloo; Ali Movafeghi; Abbas Delazar; Hosein Nazemiyeh; Solmaz Asnaashari; Mohammad Reza Dadpour
Journal:  EXCLI J       Date:  2012-07-25       Impact factor: 4.068

4.  Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance.

Authors:  Ping Jiang; Dufang Ma; Xue Wang; Yongcheng Wang; Yuxin Bi; Jinlong Yang; Xuebing Wang; Xiao Li
Journal:  Mol Cells       Date:  2018-03-20       Impact factor: 5.034

5.  GC-MS Based Identification of the Volatile Components of Six Astragalus Species from Uzbekistan and Their Biological Activity.

Authors:  Haidy A Gad; Nilufar Z Mamadalieva; Stefan Böhmdorfer; Thomas Rosenau; Gokhan Zengin; Rano Z Mamadalieva; Nawal M Al Musayeib; Mohamed L Ashour
Journal:  Plants (Basel)       Date:  2021-01-08

6.  Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity.

Authors:  Zhixiao Luo; Yaqi Wang; Mengzhen Xue; Fangqi Xia; Leiqi Zhu; Yuanyang Li; Dengke Jia; Silong Chen; Guangfu Xu; Yan Lei
Journal:  J Cell Mol Med       Date:  2021-08-17       Impact factor: 5.310

7.  Identification of Potent Bioassay Guided Terpenoid and Glycoside Root Fractions of Astragalus candolleanus against Clinically Significant Bacterial Strains.

Authors:  Kandasamy Nagarajan; Roma Ghai; Garima Varshney; Parul Grover; Carlo Genovese; Floriana D'Angeli; Richa Goel; Thota Prasad; Muthusamy Kalaivani; Anil Kumar Teotia
Journal:  Int J Microbiol       Date:  2022-04-28

8.  Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network.

Authors:  Hui Wu; Yan Gao; Hai-Lian Shi; Li-Yue Qin; Fei Huang; Yun-Yi Lan; Bei-Bei Zhang; Zhi-Bi Hu; Xiao-Jun Wu
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

9.  Evaluation of Phytochemical, Antioxidant and Antibacterial Activity on Astragalus Chrysostachys Boiss. Roots.

Authors:  Javad Ghasemian-Yadegari; Sanaz Hamedeyazdan; Hossein Nazemiyeh; Fatemeh Fathiazad
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.